Why Is Apimeds Pharmaceuticals Stock Gaining Monday?
Apimeds stock (APUS) jumped over 43% following a 2-year insurance blockchain deal between subsidiary MindWave and BlockAssure.
Stocks · News reference
Apimeds Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 30.94%
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Apimeds Pharmaceuticals shares are trading higher after the company announced its subsidiary, MindWave Innovations, signed a 2-year master maintenance and service agreement with BlockAssure.
Apimeds' MindWave Announces 2-Year Contract To Build, Run Insurance Blockchain For BlockAssure, With 20% Of Planned Token Supply; Fees Not Disclosed